Postmenopausal women with vulvovaginal atrophy treated with intravaginal prasterone for at least 12 weeks were nearly 50% ...

A large study that retrospectively analyzed the visual outcomes and rate of development of neovascular age-related macular ...

Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

The Valentine Plunge has raised nearly $5 million for the Joan Dancy and P.A.L.S. (People with ALS) Foundation.

Featured in Google Workspace’s upcoming Super Bowl ad, Travel Blogger and Accessibility Advocate Cory Lee is proving that ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.